# Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial

> **NCT06629896** · NA · RECRUITING · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 2200 (estimated)

## Conditions studied

- Breast Cancer Screening and Diagnosis

## Interventions

- **DIAGNOSTIC_TEST:** Contrast Enhancement Mammography
- **DIAGNOSTIC_TEST:** magnetic resonance imaging (MRI) and digital mammography (DM)

## Key facts

- **NCT ID:** NCT06629896
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2028-07-07
- **Final completion:** 2030-01-07
- **Target enrollment:** 2200 (ESTIMATED)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06629896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06629896, "Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT06629896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*